SCHEMBL31661791

SCHEMBL31661791

COC(=O)c1cccc(N2CC(C)(OC)C2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 1/20 0.54
▸ HRH3 Q9Y5N1 2/20 0.47
▸ OGA O60502 1/20 0.46
▸ IRAK4 Q9NWZ3 1/20 0.44
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ MAPT P10636 4/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ HSD11B1 P28845 3/20 0.38
▸ JAK2 O60674 1/20 0.37
▸ JAK1 P23458 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30080407 0.81 CRBN (0.52) CRBNHRH3OGAIRAK4MEN1
SCHEMBL31661656 0.81 CRBN (0.36) CRBN
SCHEMBL14879861 0.80 HRH3 (0.58) CRBNHRH3OGAIRAK4MEN1
SCHEMBL31661595 0.80 CRBN (0.35) CRBNMEN1KMT2AALDH1A1
SCHEMBL20548134 0.78 HSD11B1 (0.59) CRBNHRH3OGAIRAK4MEN1
SCHEMBL20000452 0.78 PRKCQ (0.61) CRBNHRH3OGAIRAK4MEN1
SCHEMBL31661756 0.77 MAP3K12 (0.37) CRBNOGAMEN1KMT2AALDH1A1
SCHEMBL3173613 0.77 OGA (0.56) CRBNHRH3OGAIRAK4MEN1
SCHEMBL22849533 0.76 IRAK4 (0.53) CRBNHRH3OGAIRAK4MAPT
SCHEMBL31078811 0.76 IRAK4 (0.53) CRBNHRH3OGAIRAK4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151403-A1 6-MEMBERED TRPML1 AGONISTS AND USES THEREOF LIBRA THERAPEUTICS, INC. (US) 2025-07-17 — — WO disclosed
Send feedback